AMAG Pharmaceuticals año OPV
¿Qué es el año OPV de AMAG Pharmaceuticals?
El año OPV de AMAG Pharmaceuticals, Inc. es 1986
¿Cuál es la definición de año OPV?
La oferta pública inicial es un tipo de oferta pública en la cual las acciones de una compañía generalmente se venden a inversionistas institucionales que, a su vez, venden al público en general, en una bolsa de valores, por primera vez.
Through IPO a privately held company transforms into a public company. Initial public offerings are mostly used by companies to raise the expansion of capital, possibly to monetize the investments of early private investors, and to become publicly traded enterprises. A company selling shares is never required to repay the capital to its public investors. After the IPO, when shares trade freely in the open market, money passes between public investors.
Although IPO offers many advantages, there are also significant disadvantages, chief among these are the costs associated with the process and the requirement to disclose certain information that could prove helpful to competitors.
The IPO process is colloquially known as going public. Details of the proposed offering are disclosed to potential purchasers in the form of a lengthy document known as a prospectus. Most companies undertake an IPO with the assistance of an investment banking firm acting in the capacity of an underwriter. Underwriters provide several services, including help with correctly assessing the value of shares.
año OPV de compañías en Sector Health Care en NASDAQ en comparadas con AMAG Pharmaceuticals
¿Qué hace AMAG Pharmaceuticals?
AMAG Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. The firm focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. Its products include Intrarosa, Vyleesi, Makena, CBR, Feraheme, and MuGard. The company was founded on November 9, 1981 and is headquartered in Waltham, MA.
Empresas con año opv similar a AMAG Pharmaceuticals
- Healthpeak Properties tiene año OPV de 1985
- Rada Electronic Industries tiene año OPV de 1985
- Capstead Mortgage tiene año OPV de 1985
- Bryn Mawr Bank tiene año OPV de 1985
- Ross Stores tiene año OPV de 1985
- Honeywell International Inc tiene año OPV de 1985
- AMAG Pharmaceuticals tiene año OPV de 1986
- Banco Santander S.A tiene año OPV de 1987
- Berry Corp tiene año OPV de 1987
- Immucell tiene año OPV de 1987
- Psychemedics tiene año OPV de 1987
- Destination XL Inc tiene año OPV de 1987
- High Income Securities Fund tiene año OPV de 1987